Indications for Sleeve Gastrectomy—Is It Worth Waiting for Comorbidities to Develop?
(1) <i>Background and Objectives:</i> Morbid obesity significantly increases the prevalence of comorbidities, such as heart disease, restrictive lung disease, stroke, diabetes mellitus and more. (2) <i>Methods</i>: Patients undergoing gastric sleeve surgery were divided into...
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2023-11-01
|
| Series: | Medicina |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1648-9144/59/12/2092 |
| _version_ | 1797380102151995392 |
|---|---|
| author | Zsuzsanna Németh Miklós Siptár Natália Tóth Krisztina Tóth Csaba Csontos Zoltán Kovács-Ábrahám Alexandra Csongor Ferenc Molnár Zsombor Márton Sándor Márton |
| author_facet | Zsuzsanna Németh Miklós Siptár Natália Tóth Krisztina Tóth Csaba Csontos Zoltán Kovács-Ábrahám Alexandra Csongor Ferenc Molnár Zsombor Márton Sándor Márton |
| author_sort | Zsuzsanna Németh |
| collection | DOAJ |
| description | (1) <i>Background and Objectives:</i> Morbid obesity significantly increases the prevalence of comorbidities, such as heart disease, restrictive lung disease, stroke, diabetes mellitus and more. (2) <i>Methods</i>: Patients undergoing gastric sleeve surgery were divided into three groups with BMI between 30–34.9 kg/m<sup>2</sup> (Group I), 35–39.9 kg/m<sup>2</sup> (Group II), and over 40 kg/m<sup>2</sup> (Group III). Preoperative examinations included cardiac ultrasound, respiratory function and laboratory tests, and preoperative comorbidities were also recorded. Following a one-year follow-up, we compared the rate of weight loss in the three groups at six months and one year following surgery, specifically, the effect of surgery on preoperative comorbidities at one year. (3) <i>Results</i>: The weight loss surgeries performed were successful in all three groups. Preoperative laboratory examinations, an echocardiogram and respiratory function results showed no clinically significant difference, except moderate elevations in blood lipid levels. Hypertension was the most common comorbidity. (4) <i>Conclusions</i>: In our patient population, hypertension and diabetes were the only comorbidities with a high prevalence. It can be explained by the relatively younger age among the patients (mean age 44.5 years) and the fact that they had not yet developed the pathological consequences of severe obesity. Consequently, while performing the surgery at a relatively younger age, it seems far more likely that the patient will return to a more active and productive life and enjoy a better quality of life. Additionally, the perioperative risk is lower, and the burden upon health systems and health expenditure is reduced by preventing comorbidities, in particular, multimorbidity. On this basis, it may be advisable to direct patients who do not exhaust the classical indications for bariatric surgery toward the surgical solution at a younger age. Our results suggest it is not worth waiting for comorbidities, especially multimorbidity, to appear. |
| first_indexed | 2024-03-08T20:33:19Z |
| format | Article |
| id | doaj.art-028120f220764f4ebbff764a1c9bcc70 |
| institution | Directory Open Access Journal |
| issn | 1010-660X 1648-9144 |
| language | English |
| last_indexed | 2024-03-08T20:33:19Z |
| publishDate | 2023-11-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Medicina |
| spelling | doaj.art-028120f220764f4ebbff764a1c9bcc702023-12-22T14:23:46ZengMDPI AGMedicina1010-660X1648-91442023-11-015912209210.3390/medicina59122092Indications for Sleeve Gastrectomy—Is It Worth Waiting for Comorbidities to Develop?Zsuzsanna Németh0Miklós Siptár1Natália Tóth2Krisztina Tóth3Csaba Csontos4Zoltán Kovács-Ábrahám5Alexandra Csongor6Ferenc Molnár7Zsombor Márton8Sándor Márton9Medical Skills Education and Innovation Centre, Medical School, University of Pécs, 7624 Pécs, HungaryDepartment of Anaesthesiology and Intensive Therapy, Medical School, University of Pécs, 7624 Pécs, HungaryDepartment of Anaesthesiology and Intensive Therapy, Medical School, University of Pécs, 7624 Pécs, HungaryDepartment of Anaesthesiology and Intensive Therapy, Medical School, University of Pécs, 7624 Pécs, HungaryDepartment of Anaesthesiology and Intensive Therapy, Medical School, University of Pécs, 7624 Pécs, HungaryDepartment of Anaesthesiology and Intensive Therapy, Medical School, University of Pécs, 7624 Pécs, HungaryDepartment of Languages for Biomedical Purposes and Communication, Medical School, University of Pécs, 7624 Pécs, HungaryMedical Skills Education and Innovation Centre, Medical School, University of Pécs, 7624 Pécs, HungaryDepartment of Anatomy, Medical School, University of Pécs, 7624 Pécs, HungaryDepartment of Anaesthesiology and Intensive Therapy, Medical School, University of Pécs, 7624 Pécs, Hungary(1) <i>Background and Objectives:</i> Morbid obesity significantly increases the prevalence of comorbidities, such as heart disease, restrictive lung disease, stroke, diabetes mellitus and more. (2) <i>Methods</i>: Patients undergoing gastric sleeve surgery were divided into three groups with BMI between 30–34.9 kg/m<sup>2</sup> (Group I), 35–39.9 kg/m<sup>2</sup> (Group II), and over 40 kg/m<sup>2</sup> (Group III). Preoperative examinations included cardiac ultrasound, respiratory function and laboratory tests, and preoperative comorbidities were also recorded. Following a one-year follow-up, we compared the rate of weight loss in the three groups at six months and one year following surgery, specifically, the effect of surgery on preoperative comorbidities at one year. (3) <i>Results</i>: The weight loss surgeries performed were successful in all three groups. Preoperative laboratory examinations, an echocardiogram and respiratory function results showed no clinically significant difference, except moderate elevations in blood lipid levels. Hypertension was the most common comorbidity. (4) <i>Conclusions</i>: In our patient population, hypertension and diabetes were the only comorbidities with a high prevalence. It can be explained by the relatively younger age among the patients (mean age 44.5 years) and the fact that they had not yet developed the pathological consequences of severe obesity. Consequently, while performing the surgery at a relatively younger age, it seems far more likely that the patient will return to a more active and productive life and enjoy a better quality of life. Additionally, the perioperative risk is lower, and the burden upon health systems and health expenditure is reduced by preventing comorbidities, in particular, multimorbidity. On this basis, it may be advisable to direct patients who do not exhaust the classical indications for bariatric surgery toward the surgical solution at a younger age. Our results suggest it is not worth waiting for comorbidities, especially multimorbidity, to appear.https://www.mdpi.com/1648-9144/59/12/2092obesityobesity surgerybariatric surgerygastrectomycomorbidityhypertension remission |
| spellingShingle | Zsuzsanna Németh Miklós Siptár Natália Tóth Krisztina Tóth Csaba Csontos Zoltán Kovács-Ábrahám Alexandra Csongor Ferenc Molnár Zsombor Márton Sándor Márton Indications for Sleeve Gastrectomy—Is It Worth Waiting for Comorbidities to Develop? Medicina obesity obesity surgery bariatric surgery gastrectomy comorbidity hypertension remission |
| title | Indications for Sleeve Gastrectomy—Is It Worth Waiting for Comorbidities to Develop? |
| title_full | Indications for Sleeve Gastrectomy—Is It Worth Waiting for Comorbidities to Develop? |
| title_fullStr | Indications for Sleeve Gastrectomy—Is It Worth Waiting for Comorbidities to Develop? |
| title_full_unstemmed | Indications for Sleeve Gastrectomy—Is It Worth Waiting for Comorbidities to Develop? |
| title_short | Indications for Sleeve Gastrectomy—Is It Worth Waiting for Comorbidities to Develop? |
| title_sort | indications for sleeve gastrectomy is it worth waiting for comorbidities to develop |
| topic | obesity obesity surgery bariatric surgery gastrectomy comorbidity hypertension remission |
| url | https://www.mdpi.com/1648-9144/59/12/2092 |
| work_keys_str_mv | AT zsuzsannanemeth indicationsforsleevegastrectomyisitworthwaitingforcomorbiditiestodevelop AT miklossiptar indicationsforsleevegastrectomyisitworthwaitingforcomorbiditiestodevelop AT nataliatoth indicationsforsleevegastrectomyisitworthwaitingforcomorbiditiestodevelop AT krisztinatoth indicationsforsleevegastrectomyisitworthwaitingforcomorbiditiestodevelop AT csabacsontos indicationsforsleevegastrectomyisitworthwaitingforcomorbiditiestodevelop AT zoltankovacsabraham indicationsforsleevegastrectomyisitworthwaitingforcomorbiditiestodevelop AT alexandracsongor indicationsforsleevegastrectomyisitworthwaitingforcomorbiditiestodevelop AT ferencmolnar indicationsforsleevegastrectomyisitworthwaitingforcomorbiditiestodevelop AT zsombormarton indicationsforsleevegastrectomyisitworthwaitingforcomorbiditiestodevelop AT sandormarton indicationsforsleevegastrectomyisitworthwaitingforcomorbiditiestodevelop |